Related Experiment Video
Updated: May 4, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches
Luca Carlino1, Peter C Astles1, Bryony Ackroyd2
1Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.
Researchers identified potent inhibitors targeting the NSD2-PWWP1 domain, a crucial protein in cancer. This discovery offers new tools for studying nuclear receptor-binding SET domain 2 (NSD2) dysregulation and developing targeted cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Chemistry
Background:
- Dysregulation of histone methyl transferase nuclear receptor-binding SET domain 2 (NSD2) is linked to various cancers.
- NSD2, a multidomain protein, possesses both histone writing and reading functions.
- Developing potent and selective NSD2 inhibitors targeting its enzymatic activity is challenging.
Purpose of the Study:
- To explore small molecules targeting the NSD2-PWWP1 domain as an alternative inhibition strategy.
- To identify high-affinity binders for the NSD2-PWWP1 domain using computational chemistry.
- To provide novel chemical tools for investigating NSD2 function in human cancers.
Main Methods:
- Employed advanced computational chemistry techniques, including free energy perturbation coupled to machine learning (FEP/ML) models.
- Utilized virtual screening (VS) activities to identify potential NSD2-PWWP1 binders.
- Synthesized and characterized identified compounds for binding affinity.
Main Results:
- Identified novel high-affinity binders for the NSD2-PWWP1 domain.
- Discovered compound 34, the most potent NSD2-PWWP1 binder reported to date (pIC50 = 8.2).
- Validated the efficacy of computational approaches in identifying selective enzyme inhibitors.
Conclusions:
- The identified compounds serve as valuable tools for studying the role of PWWP1 domains in NSD2 inhibition.
- This work demonstrates the potential of FEP/ML and VS in drug discovery for challenging targets like NSD2.
- The findings pave the way for developing novel therapeutic strategies against NSD2-driven malignancies.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
09:19NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
Published on: June 4, 2021
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...